Apimeds Pharmaceuticals US appoints Sungjoon Chae to board
Apimeds Pharmaceuticals US said Sungjoon Chae joined its board effective Sept. 10, 2026. It also said he has served as co-chief executive officer since May 4, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.